山东大学耳鼻喉眼学报 ›› 2021, Vol. 35 ›› Issue (3): 70-80.doi: 10.6040/j.issn.1673-3770.0.2020.374

• 临床研究 • 上一篇    下一篇

益生菌治疗变应性鼻炎的临床疗效及抗变态反应作用Meta分析

林小燕,李静,马志祺,李依琳,高馨怡,李勇   

  1. 浙江大学医学院附属杭州市第一人民医院 耳鼻咽喉科, 浙江 杭州 310000
  • 发布日期:2021-05-14
  • 通讯作者: 李勇. E-mail:leeyung828@163.com
  • 基金资助:
    浙江省医药卫生项目(2016KYB227);杭州市医药卫生项目(2017A10);浙江省医药卫生青年人才项目(2019RC066)

Therapeutic and anti-allergic effects of probiotics on allergic rhinitis: a meta-analysis

LIN Xiaoyan, LI Jing, MA Zhiqi, LI Yilin, GAO Xinyi, LI Yong   

  1. Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310000, Zhejiang, China
  • Published:2021-05-14

摘要: 目的 系统性评价益生菌对变应性鼻炎的疗效及抗变态反应作用的影响。 方法 计算机检索PubMed、Cochrane Library、Embase、中国知网、万方和维普数据库,收集以益生菌为干预措施治疗变应性鼻炎的随机对照试验(RCT),检索时限从建库截至2020年3月。由2名研究者按照纳入与排除标准独立筛选文献、提取资料和评价纳入研究的方法学质量,并采用RevMan5.3软件进行Meta分析。 结果 总共纳入27个RCT,共2 147例患者,其中试验组1 106例,对照组1 041例。Meta分析结果显示:长期口服益生菌(≥12周)可以降低过敏性鼻炎患者血清总IgE水平[SMD=-0.22,95%CI(-0.42,-0.02),P=0.03<0.05]及血嗜酸性粒细胞水平[SMD=-0.38,95%CI(-0.69,-0.08),P=0.01<0.05];且益生菌组的鼻部RQLQ[MD=-0.78,95%CI(-0.96,-0.61),P<0.000 01]、眼部RQLQ评分[MD=-0.75,95%CI(-0.90,-0.60),P<0.001]、TNSS评分[MD=-1.54,95%CI(-1.77,-1.31),P<0.001]及药物使用评分[SMD=-0.43,95%CI(-0.64,-0.22),P<0.000 01]均较安慰组较低,差异有统计学意义。但益生菌组较安慰剂组在降低血清特异性IgE水平[SMD=0.08,95%CI(-0.11,0.26),P=0.42]及调节Th1/Th2平衡[SMD=0.40,95%CI(-1.20,1.99), P=0.63]方面差异无统计学意义。 结论 口服益生菌可以有效的控制变应性鼻炎患者的过敏症状,虽然短期内口服益生菌对AR 的发生无明显预防作用,但长期服用可以降低血清总IgE水平及嗜酸性粒细胞计数水平,证明长期口服益生菌可能是治疗变应性鼻炎的一种疗效和安全性较为理想的辅助治疗手段。

关键词: 益生菌, 变应性鼻炎, 随机对照实验, 疗效, IgE, Th1/Th2, 嗜酸性粒细胞, Meta分析

Abstract: Objective To systemically review the therapeutic and anti-allergic effects of probiotics on allergic rhinitis(AR). Methods Publications from PubMed, the Cochrane Library, Embase, CNKI, WanFang, and VIP databases were searched from inception to February 2020. Two reviewers extracted the data and performed literature evaluation. Revman 5.3 software was used for meta-analysis. Results A total of 27 randomized controlled trials comprising 2 147 patients(1 106 patients in the probiotics group and 1 041 patients in the placebo group)were included. The results of meta-analysis showed that probiotics reduced serum total IgE [SMD=-0.22, 95%CI(-0.42, -0.02), P=0.03<0.05] and eosinophil level [SMD=-0.38, 95%CI(-0.69, -0.08), P=0.01<0.05]. Rhinoconjunctivitis quality of life questionnaire(RQLQ)nose symptoms [MD=-0.78, 95%CI(-0.96, -0.61), P<0.001], RQLQ eye symptoms [MD=-0.78, 95%CI(-0.96, -0.61), P<0.000 01], the total nasal symptom score [MD=-1.54, 95%CI(-1.77, -1.31), P<0.001], and medication scores [SMD=-0.43, 95%CI(-0.64, -0.22), P<0.001] were significantly lower in the placebo group. However, specific IgE [SMD=0.08, 95%CI(-0.11, 0.26), P=0.42] and Th1/Th2 ratio [SMD=0.40,95%CI(-1.20, 1.99), P=0.63] were not statistically different between the groups. Conclusion Probiotics effectively reduced symptom scores of patients with AR compared with placebo. Although short-term use of probiotics showed no significant preventive effects on AR, their long-term use reduced serum total IgE level and eosinophil count. Taken together, probiotics can be suggested as an effective treatment for AR.

Key words: Probiotics, Allergic rhinitis, Randomized controlled trials, Efficacy, IgE, Th1/Th2, Eosinophil, Meta-analysis

中图分类号: 

  • R765
[1] Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: Allergic rhinitis[J]. Otolaryngol Head Neck Surg, 2015, 152(1 suppl): S1-43. doi:10.1177/0194599814561600.
[2] Bousquet J, Schünemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma(ARIA)guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation(GRADE)and real-world evidence[J]. J Allergy Clin Immunol, 2020, 145(1): 70-80.e3. doi:10.1016/j.jaci.2019.06.049.
[3] Wallace DV, Dykewicz MS, Oppenheimer J, et al. Pharmacologic treatment of seasonal allergic rhinitis: synopsis of guidance from the 2017 joint task force on practice parameters[J]. Ann Intern Med, 2017, 167(12): 876. doi:10.7326/m17-2203.
[4] Yan F, Polk DB. Probiotics and immune health[J]. Curr Opin Gastroenterol, 2011, 27(6): 496-501. doi:10.1097/mog.0b013e32834baa4d.
[5] Colbey C, Cox AJ, Pyne DB, et al. Upper respiratory symptoms, gut health and mucosal immunity in Athletes[J]. Sports Med, 2018, 48(1): 65-77. doi:10.1007/s40279-017-0846-4.
[6] Dennis-Wall JC, Culpepper T, Nieves C, et al. Probiotics(Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2)improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial[J]. Am J Clin Nutr, 2017, 105(3): 758-767. doi:10.3945/ajcn.116.140012.
[7] Chen YS, Jan RL, Lin YL, et al. Randomized placebo-controlled trial of Lactobacillus on asthmatic children with allergic rhinitis[J]. Pediatr Pulmonol, 2010, 45(11): 1111-1120. doi:10.1002/ppul.21296.
[8] Ciprandi G, Vizzaccaro A, Cirillo I, et al. Bacillus clausii effects in children with allergic rhinitis[J]. Allergy, 2005, 60(5): 702-703. doi:10.1111/j.1398-9995.2005.00722.x.
[9] Miraglia del Giudice M, Indolfi C, Capasso M, et al. Bifidobacterium mixture(B longum BB536, B infantis M-63, B breve M-16V)treatment in children with seasonal allergic rhinitis and intermittent asthma[J]. Italian J Pediatr, 2017, 43(1): 1-6. doi:10.1186/s13052-017-0340-5.
[10] Costa DJ, Marteau P, Amouyal M, et al. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial(GA2LEN Study)[J]. Eur J Clin Nutr, 2014, 68(5): 602-607. doi:10.1038/ejcn.2014.13.
[11] Giovannini M, Agostoni C, Riva E, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis[J]. Pediatr Res, 2007, 62(2): 215-220. doi:10.1203/pdr.0b013e3180a76d94.
[12] Ishida Y, Nakamura F, Kanzato H, et al. Effect of milk fermented with Lactobacillus acidophilus strain L-92 on symptoms of Japanese cedar pollen allergy: a randomized placebo-controlled trial[J]. Biosci Biotechnol Biochem, 2005, 69(9): 1652-1660. doi:10.1271/bbb.69.1652.
[13] Ishida Y, Nakamura F, Kanzato H, et al. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study[J]. J Dairy Sci, 2005, 88(2): 527-533. doi:10.3168/jds.S0022-0302(05)72714-4.
[14] Lin WY, Fu LS, Lin HK, et al. evaluation of the effect of Lactobacillus paracasei(HF.A00232)in children(6-13 years old)with perennial allergic rhinitis: a 12-week, Double-blind, randomized, Placebo-controlled study[J]. Pediatr Neonatol, 2014, 55(3): 181-188. doi:10.1016/j.pedneo.2013.10.001.
[15] Lin TY, Chen CJ, Chen LK, et al. Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled trial[J]. Indian Pediatr, 2013, 50(2): 209-213. doi:10.1007/s13312-013-0068-2.
[16] Kawase M, He F, Kubota A, et al. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study[J]. Int J Food Microbiol, 2009, 128(3): 429-434. doi:10.1016/j.ijfoodmicro.2008.09.017.
[17] Meng Q, Li P, Li Y, et al. Broncho-vaxom alleviates persistent allergic rhinitis in patients by improving Th1/Th2 cytokine balance of nasal mucosa[J]. Rhinology, 2019, 57(6): 451-459. doi:10.4193/rhin19.161.
[18] Moreira A, Kekkonen R, Korpela R, et al. Allergy in marathon runners and effect of Lactobacillus GG supplementation on allergic inflammatory markers[J]. Respir Med, 2007, 101(6): 1123-1131. doi:10.1016/j.rmed.2006.11.015.
[19] Nishimura I, Igarashi T, Enomoto T, et al. Clinical efficacy of halophilic lactic acid bacterium Tetragenococcus halophilus Th221 from soy sauce moromi for perennial allergic rhinitis[J]. Allergol Int, 2009, 58(2): 179-185. doi:10.2332/allergolint.O-08-548.
[20] Ogawa T, Hashikawa S, Asai Y, et al. A new synbiotic, Lactobacillus casei subsp.caseitogether with dextran, reduces murine and human allergic reaction[J]. FEMS Immunol Med Microbiol, 2006, 46(3): 400-409. doi:10.1111/j.1574-695x.2006.00046.x.
[21] Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite[J]. Pediatr Allergy Immunol, 2005, 16(5): 433-438. doi:10.1111/j.1399-3038.2005.00284.x.
[22] Tamura M, Shikina T, Morihana T, et al. Effects of probiotics on allergic rhinitis induced by Japanese cedar pollen: randomized double-blind, placebo-controlled clinical trial[J]. Int Arch Allergy Immunol, 2007, 143(1): 75-82. doi:10.1159/000098318.
[23] Wang MF, Lin HC, Wang YY, et al. Treatment of perennial allergic rhinitis with lactic acid bacteria[J]. Pediatr Allergy Immunol, 2004, 15(2): 152-158. doi:10.1111/j.1399-3038.2004.00156.x.
[24] Xiao JZ, Kondo S, Yanagisawa N, et al. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial[J]. J Investig Allergol Clin Immunol, 2006, 16(2): 86-93.
[25] Xiao JZ, Kondo S, Yanagisawa N, et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial[J]. Clin Exp Allergy, 2006, 36(11): 1425-1435. doi:10.1111/j.1365-2222.2006.02575.x.
[26] Gotoh M, Sashihara T, Ikegami S, et al. Efficacy of oral administration of a heat-killed Lactobacillus gasseri OLL2809 on patients of Japanese cedar pollinosis with high Japanese-cedar pollen-specific IgE[J]. Biosci Biotechnol Biochem, 2009, 73(9): 1971-1977. doi:10.1271/bbb.90144.
[27] Yonekura S, Okamoto Y, Okawa T, et al. Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis[J]. Allergy Asthma Proc, 2009, 30(4): 397-405. doi:10.2500/aap.2009.30.3256.
[28] Nagata Y, Yoshida M, Kitazawa H, et al. Improvements in seasonal allergic disease with Lactobacillus plantarum no. 14[J]. Biosci Biotechnol Biochem, 2010, 74(9): 1869-1877. doi:10.1271/bbb.100270.
[29] Lue KH, Sun HL, Lu KH, et al. A trial of adding Lactobacillus johnsonii EM1 to levocetirizine for treatment of perennial allergic rhinitis in children aged 7-12 years[J]. Int J Pediatr Otorhinolaryngol, 2012, 76(7): 994-1001. doi:10.1016/j.ijporl.2012.03.018.
[30] Singh A, Hacini-Rachinel F, Gosoniu ML, et al. Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial[J]. Eur J Clin Nutr, 2013, 67(2): 161-167. doi:10.1038/ejcn.2012.197.
[31] Dölle S, Berg J, Rasche C, et al. Tolerability and clinical outcome of coseasonal treatment with Escherichia coli Strain nissle 1917 in grass pollen-allergic subjects[J]. Int Arch Allergy Immunol, 2014, 163(1): 29-35. doi:10.1159/000356328.
[32] 陈红江, 高明华, 邹帆, 等. 特异益生菌株对变应性鼻炎患者的免疫调节作用[J]. 第三军医大学学报, 2015, 37(2): 154-157. doi:10.16016/j.1000-5404.201408120. CHEN Hongjiang, GAO Minghua, ZOU Fan, et al. Immunomodulation effect of specific probiotics in allergic rhinitis patients[J]. Journal of Third Military Medical University, 2015, 37(2): 154-157. doi:10.16016/j.1000-5404.201408120.
[33] Kim HJ, Kim HY, Lee SY, et al. Clinical efficacy and mechanism of probiotics in allergic diseases[J]. Korean J Pediatr, 2013, 56(9): 369-376. doi:10.3345/kjp.2013.56.9.369.
[34] Zhou Z, Chen X, Sheng H, et al. Engineering probiotics as living diagnostics and therapeutics for improving human health[J]. Microb Cell Fact, 2020, 19(1): 56. doi:10.1186/s12934-020-01318-z.
[35] 张清照, 嶋田貴志, 程雷,等. 肠球菌属益生菌提取物LFK对变应性鼻炎小鼠血清IL-12的影响[J]. 山东大学耳鼻喉眼学报, 2014, 28(3): 7-9. doi:10.6040/j.issn.1673-3770.0.2014.154. ZHANG Qingzhao, SHIMADA Takashi, CHENG Lei, et al. Effect of lysed enterococcus faecalis FK-23(LFK)on serum IL-12 in allergic rhinitis mice[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2014, 28(3): 7-9.doi:10.6040/j.issn.1673-3770.0.2014.154.
[36] Vliagoftis H, Kouranos VD, Betsi GI, et al. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials[J]. Ann Allergy Asthma Immunol, 2008, 101(6): 570-579. doi:10.1016/S1081-1206(10)60219-0.
[1] 李仕运,谢艳,潘佳煜,陈美馨,龙丹,张春林. 人工耳蜗植入对老年语后聋患者疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 20-30.
[2] 方璐, 雷玉丹, 王华. 环孢素滴眼液联合玻璃酸钠滴眼液治疗干眼临床效果的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 65-73.
[3] 吕倩,唐源,顾子君,施赛磊,刘萍,万文锦. 变应性鼻炎患者疾病获益感现状及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 21-28.
[4] 雷玉丹,方璐,陈健,彭昌福. 托珠单抗治疗激素抵抗或不耐受的中重度甲状腺相关性眼病临床疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 54-67.
[5] 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[6] 孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[7] 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[8] 秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[9] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[10] 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[11] 刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[12] 尹振乾,皇甫辉. 头颈部木村病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 104-107.
[13] 张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[14] 孙春晓,王文晴,岳田,刘济生. 高低累积顺铂剂量同步放化疗治疗鼻咽癌的疗效分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 31-41.
[15] 郑泽皓,魏佳俐,刘嘉涛,周玉麒,孙文婷,李雨轩,白鹏. 特定部位针刺法治疗突发性聋的疗效及安全性评价:一项系统综述和网状Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 114-127.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!